Abstract
I have been invited to give a summary of some of the presentations on Organ donation and procurement at the American Transplant Congress held in Seattle, Washington, USA, May 21-25 2005. It is definitely not possible to give an all inclusive and neutral summary of all the information given on the subjects related to organ donation and procurement during the congress. There where for example 56 abstracts on “donation”, 23 on “NHBD”, 53 on “donors marginal” and 15 on “donors unrelated”. I will deal with some of the ones I found the most interesting and also on some of the invited presentations. It is a subjective sample of the presentations given with some comments. I hope to stimulate the reader’s appetite, by giving some information and also the numbers of the abstracts where the interested reader can find more information. The abstracts can be found in the abstract book [1]. I will also comment more in detail on some of the issues discussed at the congress and give references to webbpages and papers where more
information is available….
Keywords: procurement
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






